Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT07481539Phase 2Recruiting

Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment

Role: lead

NCT05083871Completed

Cognitive Appraisals and Team Performance Under Stress in Simulated Trauma Care

Role: collaborator

NCT06296134Not ApplicableRecruiting

Perineal Massage in Pregnancy to Reduce the Levator Ani Coactivation

Role: lead

All 4 trials loaded